Nevzorova Yulia A, Boyer-Diaz Zoe, Cubero Francisco Javier, Gracia-Sancho Jordi
Department of Genetics, Physiology and Microbiology, Faculty of Biology, Complutense University, Madrid, Spain; 12 de Octubre Health Research Institute (imas12), Madrid, Spain; Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Liver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, IDIBAPS Biomedical Research Institute, Barcelona, Spain; Barcelona Liver Bioservices, Barcelona, Spain.
J Hepatol. 2020 Aug;73(2):423-440. doi: 10.1016/j.jhep.2020.04.011. Epub 2020 Apr 21.
Animal models are crucial for improving our understanding of human pathogenesis, enabling researchers to identify therapeutic targets and test novel drugs. In the current review, we provide a comprehensive summary of the most widely used experimental models of chronic liver disease, starting from early stages of fatty liver disease (non-alcoholic and alcoholic) to steatohepatitis, advanced cirrhosis and end-stage primary liver cancer. We focus on aspects such as reproducibility and practicality, discussing the advantages and weaknesses of available models for researchers who are planning to perform animal studies in the near future. Additionally, we summarise current and prospective models based on human tissue bioengineering.
动物模型对于增进我们对人类发病机制的理解至关重要,使研究人员能够确定治疗靶点并测试新型药物。在当前的综述中,我们全面总结了最广泛使用的慢性肝病实验模型,从脂肪肝疾病(非酒精性和酒精性)的早期阶段到脂肪性肝炎、晚期肝硬化和终末期原发性肝癌。我们关注可重复性和实用性等方面,为计划在不久的将来进行动物研究的研究人员讨论现有模型的优缺点。此外,我们总结了基于人体组织生物工程的当前和未来模型。